Tech Company Financing Transactions

Korro Bio Funding Round

Wu Capital, Alexandria Venture Investments and Atlas Venture participated in a $91.5 million Series A funding round for Korro Bio. The round was announced on 9/11/2020.

Transaction Overview

Company Name
Announced On
9/11/2020
Transaction Type
Venture Equity
Amount
$91,500,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to advance its lead program to IND filing and establish a broad portfolio of innovative RNA editing therapies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA
Phone
Undisclosed
Email Address
Overview
At Korro Bio our aim is to bring transformative treatments to patients with rare and debilitating diseases by addressing the underlying genetic cause. We are utilizing the precision provided by nucleic acid-based therapeutics to target the sequences responsible within the genetic code.
Profile
Korro Bio LinkedIn Company Profile
Social Media
Korro Bio Company Twitter Account
Company News
Korro Bio News
Facebook
Korro Bio on Facebook
YouTube
Korro Bio on YouTube

Management Team

Title
Name
Email & Social
Chairman
Nessan Bermingham
  Nessan Bermingham LinkedIn Profile  Nessan Bermingham Twitter Account  Nessan Bermingham News  Nessan Bermingham on Facebook
Founder
Jean Formela
  Jean Formela LinkedIn Profile  Jean Formela Twitter Account  Jean Formela News  Jean Formela on Facebook
Founder
Joshua Rosenthal
  Joshua Rosenthal LinkedIn Profile  Joshua Rosenthal Twitter Account  Joshua Rosenthal News  Joshua Rosenthal on Facebook
Vice President
Matthew Jarpe
  Matthew Jarpe LinkedIn Profile  Matthew Jarpe Twitter Account  Matthew Jarpe News  Matthew Jarpe on Facebook
Vice President
Stuart Milstein
  Stuart Milstein LinkedIn Profile  Stuart Milstein Twitter Account  Stuart Milstein News  Stuart Milstein on Facebook
VP - Bus. Development
Yong Chang
  Yong Chang LinkedIn Profile  Yong Chang Twitter Account  Yong Chang News  Yong Chang on Facebook
VP - Engineering
Andrew Fraley
  Andrew Fraley LinkedIn Profile  Andrew Fraley Twitter Account  Andrew Fraley News  Andrew Fraley on Facebook
VP - General Counsel
Anna Barry
  Anna Barry LinkedIn Profile  Anna Barry Twitter Account  Anna Barry News  Anna Barry on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/11/2020: Casma Therapeutics venture capital transaction
Next: 9/11/2020: Orchard venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary